Atopic dermatitis Trials in Long Beach, United States
Conditions / Atopic dermatitis / Long Beach, United States
Atopic dermatitis is a medical condition with active clinical research programs worldwide.
21 total trials for this combination
Showing top 10 of 21 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT03607422 | A Study to Evaluate Upadacitinib in Adolescents and Adults With Moderate to Severe Atopic Dermatitis (Measure Up 2) | COMPLETED | PHASE3 |
| NCT04345367 | Study of Abrocitinib Compared With Dupilumab in Adults With Moderate to Severe Atopic Dermatitis on Background Topical Therapy | COMPLETED | PHASE3 |
| NCT03568331 | Evaluating the Effects of Tradipitant vs. Placebo in Atopic Dermatitis (EPIONE) | COMPLETED | PHASE3 |
| NCT05882877 | A Study to Assess Long-term Safety, Tolerability, and Efficacy of Rocatinlimab in Adult and Adolescent Participants With Moderate-to-severe Atopic Dermatitis (AD) | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT05899816 | A Study Assessing Rocatinlimab on Vaccine Antibody Response in Moderate-to-severe Atopic Dermatitis (AD) (ROCKET - VOYAGER) | COMPLETED | PHASE3 |
| NCT02210780 | Study of Dupilumab and Immune Responses in Adults With Atopic Dermatitis (AD) | COMPLETED | PHASE2 |
| NCT01949311 | Open-label Study of Dupilumab in Patients With Atopic Dermatitis | COMPLETED | PHASE3 |
| NCT02612454 | Study to Assess the Long-term Safety of Dupilumab Administered in Participants ≥6 Months to <18 Years of Age With Atopic Dermatitis (AD) | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT05142774 | Long Term Extension Study of Tapinarof Cream, 1% for Subjects With Atopic Dermatitis | COMPLETED | PHASE3 |
| NCT05398445 | A Study Evaluating Rocatinlimab in Moderate-to-severe Atopic Dermatitis (ROCKET-IGNITE) | COMPLETED | PHASE3 |